SUN Juan, LIU Jianzhou, WEN Jin, LI Hanzhong, JI Zhigang, DONG Dexin, YE Zixing, MIAO Qi, TONG Anli, HUANG Yuguang, LONG Yun. Carotid Body Tumor, Cardiac Paraganglioma, Adrenal Pheochromocytoma: A Contest with Hypercatecholamineemia[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 1022-1029. DOI: 10.12290/xhyxzz.2021-0134
Citation: SUN Juan, LIU Jianzhou, WEN Jin, LI Hanzhong, JI Zhigang, DONG Dexin, YE Zixing, MIAO Qi, TONG Anli, HUANG Yuguang, LONG Yun. Carotid Body Tumor, Cardiac Paraganglioma, Adrenal Pheochromocytoma: A Contest with Hypercatecholamineemia[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 1022-1029. DOI: 10.12290/xhyxzz.2021-0134

Carotid Body Tumor, Cardiac Paraganglioma, Adrenal Pheochromocytoma: A Contest with Hypercatecholamineemia

Funds: 

Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2019XK320027

Project Management Fund for Foreign Cultural and Educational Experts G20190001645

More Information
  • Corresponding author:

    WEN Jin  Tel: 86-10-69152511, E-mail: wjpumch@163.com

  • Received Date: January 28, 2021
  • Accepted Date: March 28, 2021
  • Available Online: August 31, 2021
  • Issue Publish Date: November 29, 2021
  • This patient was an elderly man with left carotid body tumor, cardiac paraganglioma and right adrenal pheochromocytoma at the same time. It was a rare case with a complex condition, and the diagnosis and treatment were difficult. After two rounds of discussion in the multidisciplinary team, our hospital successively removed the lesions of the heart and the right adrenal, and the patient was discharged smoothly after the operations. The diagnosis and treatment of this patient reflects the significance of the multidisciplinary team on the diagnosis and treatment of difficult diseases.
  • [1]
    嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36: 737-750.
    [2]
    Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979[J]. Mayo Clin Proc, 1983, 58: 802-804. http://www.ncbi.nlm.nih.gov/pubmed/6645626
    [3]
    McNeil AR, Blok BH, Koelmeyer TD, et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland[J]. Aust N Z J Med, 2000, 30: 648-652. DOI: 10.1111/j.1445-5994.2000.tb04358.x
    [4]
    Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series[J]. Mayo Clin Proc, 1981, 56: 354-360. http://europepmc.org/abstract/med/6453259
    [5]
    Scoazec JY, Couvelard A, Réseau TENpath. Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J]. Ann Pathol, 2017, 37: 444-456. DOI: 10.1016/j.annpat.2017.10.003
    [6]
    Abdelhady K, Durgam S, Orza D, et al. Left Atrial and Carotid Body Paraganglioma[J]. Ann Thorac Surg, 2017, 103: e323-e325. DOI: 10.1016/j.athoracsur.2016.09.062
    [7]
    Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients[J]. J Clin Endocrinol Metab, 2001, 86: 5210-5216. DOI: 10.1210/jcem.86.11.8034
    [8]
    Al-Harthy M, Al-Harthy S, Al-Otieschan A, et al. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas[J]. Endocr Pract, 2009, 15: 194-202. DOI: 10.4158/EP.15.3.194
    [9]
    Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification[J]. Endocr Pathol, 2012, 23: 4-14. DOI: 10.1007/s12022-011-9188-1
    [10]
    Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors[J]. Endocr Pathol, 2005, 16: 23-32. DOI: 10.1385/EP:16:1:023
    [11]
    Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases[J]. Am J Surg Pathol, 2002, 26: 551-566. DOI: 10.1097/00000478-200205000-00002
    [12]
    Strong VE, Kennedy T, Al-Ahmadie H, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis[J]. Surgery, 2008, 143: 759-768. DOI: 10.1016/j.surg.2008.02.007
    [13]
    de Wailly P, Oragano L, Radé F, et al. Malignant pheochromocytoma: new malignancy criteria[J]. Langenbecks Arch Surg, 2012, 397: 239-246. DOI: 10.1007/s00423-011-0850-3
    [14]
    Agarwal A, Mehrotra PK, Jain M, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?[J]. World J Surg, 2010, 34: 3022-3028. DOI: 10.1007/s00268-010-0744-5
    [15]
    Chen H, Sippel RS, O'Dorisio MS, et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer[J]. Pancreas, 2010, 39: 775-783. DOI: 10.1097/MPA.0b013e3181ebb4f0
    [16]
    Boedeker CC, Neumann HP, Offergeld C, et al. Clinical features of paraganglioma syndromes[J]. Skull Base, 2009, 19: 17-25. DOI: 10.1055/s-0028-1103123
    [17]
    Shen WT, Grogan R, Vriens M, et al. One Hundred Two Patients With Pheochromocytoma Treated at a Single Institution Since the Introduction of Laparoscopic Adrenalectomy[J]. Arch Surg, 2010, 145: 893-897. DOI: 10.1001/archsurg.2010.159
    [18]
    Huang KH, Chung SD, Chen SC, et al. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute[J]. Int J Urol, 2007, 14: 181-185. DOI: 10.1111/j.1442-2042.2007.01687.x
    [19]
    Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management[J]. Pediatr Nephrol, 2020, 35: 581-594. DOI: 10.1007/s00467-018-4181-2
    [20]
    Bholah R, Bunchman TE. Review of Pediatric Pheochromocytoma and Paraganglioma[J]. Front Pediatr, 2017, 5: 155. DOI: 10.3389/fped.2017.00155
  • Related Articles

    [1]WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 616-623. DOI: 10.12290/xhyxzz.2023-0454
    [2]ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
    [3]Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
    [4]Ying JIANG, Xiao-yan CHANG, Jie CHEN. Clinicopathological Features of Fibromatosis of the Breast[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 442-445. DOI: 10.3969/j.issn.1674-9081.2015.06.009
    [5]Xiao-hua SHI, Sha-fei WU, Qing LING, Zhen HUO, Zhi-yong LIANG. Clinicopathological Features and Immunohistochemical Phenotypes of Adenoid Cystic Carcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 197-201. DOI: 10.3969/j.issn.1674-9081.2015.03.007
    [6]Jing ZHANG, Jie GAO, Sha-fei WU, Tao LU, Zhi-yong LIANG. Clinicopathological Features and Epidermal Growth Factor Receptor Gene Status of Adrenocortical Oncocytic Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 191-196. DOI: 10.3969/j.issn.1674-9081.2015.03.006
    [8]Jie LIU, Tao ZHOU, Kai FANG, Dong-lai MA, Yue-hua LIU. Clinical and Pathological Characteristics of Patients with Lipodystrophia Centifugalis Abdominalis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 423-426. DOI: 10.3969/j.issn.1674-9081.2012.04.014
    [9]Xiao-feng JIN, Xing-ming CHEN, Wu-yi LI, Pei-hong PENG, Hong JIANG, Xiao-li ZHU, Ke-li CAO, Bao-quan ZHANG, Lian-shan ZHANG, Zhi-qiang GAO. Clinical and Pathological Characteristics and Treatment Outcome of Sarcoma of the Larynx[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(2): 170-174. DOI: 10.3969/j.issn.1674-9081.2012.02.009
    [10]Li GE, Rui-e FENG, Xin-lun TIAN, Ju-hong SHI, Tao LIU, Zuo-jun XU, Wen-bing XU, Wei SONG, Hong-rui LIU, Yuan-jue ZHU. Clinical and Pathological Features of Pulmonary Intravascular Lymphoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 30-35. DOI: 10.3969/j.issn.1674-9081.2012.01.008
  • Cited by

    Periodical cited type(7)

    1. 方中坚,沈家辉,汪颖霞,张亮,樊玉录,朱思琪,邵蓉,邵明立. 以患者为中心的临床试验理念及发展趋势探讨. 中国新药杂志. 2024(13): 1356-1361 .
    2. 李多静,邢永发,吴哲颖,庄铭,王保和,张莉. 中医药临床疗效评价的研究进展与思考. 天津中医药. 2024(09): 1200-1205 .
    3. 吴清,孙超,吴大维,汤骐羽,贾硕鹏,唐玉,黄慧瑶,房虹,于锋,李宁. 肿瘤受试者对以患者为中心的药物临床试验的参与意愿及其影响因素调查. 肿瘤药学. 2024(06): 653-661 .
    4. 翟静波. 以患者为中心的中医药防治慢性病临床诊疗方案遴选与评价方法学框架. 中国循证医学杂志. 2023(04): 439-443 .
    5. 吴晓蕾,史梦龙,张晨瑶,马毓聪,杜亮,刘炳林,曹璐佳,张俊华. 以患者为中心药物研发相关概念介绍. 中国循证医学杂志. 2023(12): 1472-1477 .
    6. 朱琳,胡嘉浩,康琦,许艺帆,金春林. 患者报告结局在罕见病临床研究中的应用探讨. 世界临床药物. 2022(02): 124-129 .
    7. 刘灵娟,刘珂菲,张静,张一,陈宝安. 血液学“大专家.COM”平台建设之经验. 中国现代医生. 2022(30): 123-127+142 .

    Other cited types(2)

Catalog

    Article Metrics

    Article views (499) PDF downloads (142) Cited by(9)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close